Journal
CANCER DISCOVERY
Volume 3, Issue 1, Pages 20-23Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-12-0514
Keywords
-
Categories
Funding
- Intramural NIH HHS [Z01 BC010620-04] Funding Source: Medline
Ask authors/readers for more resources
Given the malleable nature of cancer cells, we should expect, and do see, the development of resistance to any new chemotherapeutic agent. Models that help us understand how this happens are a first step to better and more effective chemotherapeutics. Cancer Discov; 3(1); 20-3. (C) 2012 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
